title: TNF-alpha release in monocytes after exposure to calcium hydroxide treated Escherichia coli LPS.
abstract: Lipopolysaccharide (LPS), a cell wall component of Gram negative anaerobic bacteria, has been implicated in the pathogenesis of periapical disease resulting from infected root canals. Calcium hydroxide [Ca(OH)2] has been shown to be an effective medicament in such infections, reducing the microbial titre within the canal. It has been proposed that the therapeutic effect of Ca(OH)2 may also be the result of direct inactivation of LPS. The aim of this study was to investigate whether the toxic potential of an Escherichia coli LPS could be reduced or eliminated by Ca(OH)2. Four concentrations of E. coli LPS ranging from 1-1000 ng/ml sterile water were incubated in duplicate either with 25 mg Ca(OH)2 or sterile water alone. Controls consisted of Ca(OH)2 without LPS or sterile water only. Monocytes were collected from peripheral blood by centrifuging through a gradient and plated to a specific density. Adherent monocytes were incubated for 4 days at 37 degrees C with 5% CO2 in M199 medium with 10% autologous serum. The different LPS solutions were added to the wells on day 5. After 4 h the supernatants were collected and quantitatively assayed for TNF-alpha using a commercial ELISA kit. Statistical analysis was performed with ANOVA. Results indicated that Ca(OH)2 is able to eliminate the ability of an E. coli LPS to stimulate TNF-alpha production in peripheral blood monocytes (P < 0.0001).
authors.affiliation: Department of Operative and Preventive Dentistry, Charité, Humboldt University, Berlin, Germany.
authors.forename: C R
authors.initials: CR
authors.lastname: Barthel
authors.forename: L G
authors.initials: LG
authors.lastname: Levin
authors.forename: H M
authors.initials: HM
authors.lastname: Reisner
authors.forename: M
authors.initials: M
authors.lastname: Trope
mesh_terms: D002126:Calcium Hydroxide / Q000494:pharmacology*; D002478:Cells, Cultured; D004336:Drug Antagonism; D004926:Escherichia coli; D006801:Humans; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors / Q000633:toxicity*; D008297:Male; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism; D012388:Root Canal Irrigants / Q000494:pharmacology*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis* / Q000187:drug effects
chemical_list: D008070:Lipopolysaccharides; D012388:Root Canal Irrigants; D014409:Tumor Necrosis Factor-alpha; D002126:Calcium Hydroxide